Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dexcom (DXCM)

Dexcom (DXCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,562,994
  • Shares Outstanding, K 91,529
  • Annual Sales, $ 1,032 M
  • Annual Income, $ -127,100 K
  • 60-Month Beta 0.64
  • Price/Sales 18.00
  • Price/Cash Flow 324.22
  • Price/Book 23.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.70
  • Number of Estimates 12
  • High Estimate 0.88
  • Low Estimate 0.38
  • Prior Year 0.54
  • Growth Rate Est. (year over year) +29.63%

Price Performance

See More
Period Period Low Period High Performance
1-Month
145.23 +42.80%
on 10/25/19
208.20 -0.39%
on 11/12/19
+54.42 (+35.58%)
since 10/15/19
3-Month
138.28 +49.98%
on 09/10/19
208.20 -0.39%
on 11/12/19
+48.86 (+30.82%)
since 08/15/19
52-Week
105.05 +97.42%
on 12/21/18
208.20 -0.39%
on 11/12/19
+71.64 (+52.77%)
since 11/15/18

Most Recent Stories

More News
San Gorgonio Hospital Picks Allscripts Sunrise Community Care

Allscripts' (MDRX) Sunrise Community Care is an Azure-hosted platform offering clinical, financial and ambulatory content.

CERN : 68.40 (+2.01%)
MDRX : 10.99 (+2.04%)
DXCM : 208.37 (+2.74%)
NXGN : 16.98 (+0.83%)
Healthcare Drives Wall Street: 5 Soaring ETFs & Stocks

Decent fundamentals and valuations as well as encouraging developments put these medical ETFs and stocks in focus.

PTH : 84.15 (+1.54%)
PBE : 52.30 (+1.49%)
XBI : 84.79 (+1.34%)
CNCR : 21.31 (+1.52%)
DXCM : 208.37 (+2.74%)
CLVS : 6.38 (+1.11%)
BIIB : 282.27 (+2.59%)
PTI : 1.05 (-0.94%)
AQST : 6.00 (-2.28%)
FTSV : 10.69 (+2.69%)
ARKG : 31.71 (+1.96%)
NextGen's Medfusion Buyout to Improve Patient Experience

NextGen (NXGN) showcases new capabilities and services for its flagship NextGen Enterprise platform.

DXCM : 208.37 (+2.74%)
CNMD : 112.99 (+0.29%)
XRAY : 56.63 (+1.07%)
NXGN : 16.98 (+0.83%)
5 Relative Price Strength Stocks to Buy for Optimum Returns

Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

LAD : 160.86 (-0.20%)
PHM : 38.92 (-1.09%)
CRUS : 72.71 (+0.62%)
DXCM : 208.37 (+2.74%)
WCG : 312.14 (+3.43%)
Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

Is (DXCM) Outperforming Other Medical Stocks This Year?

DXCM : 208.37 (+2.74%)
The Zacks Analyst Blog Highlights: Dexcom, Fortinet and Agnico Eagle

The Zacks Analyst Blog Highlights: Dexcom, Fortinet and Agnico Eagle

FTNT : 101.54 (+1.42%)
DXCM : 208.37 (+2.74%)
AEM : 58.62 (-1.01%)
SmarTrend Watching for Potential Pullback in Shares of Dexcom After 25.73% Gain

Dexcom (NASDAQ:DXCM) traded in a range yesterday that spanned from a low of $194.60 to a high of $202.37. Yesterday, the shares gained 25.7%, which took the trading range above the 3-day high of $200.80...

DXCM : 208.37 (+2.74%)
What Makes DexCom (DXCM) a Strong Momentum Stock: Buy Now?

Does DexCom (DXCM) have what it takes to be a top stock pick for momentum investors? Let's find out.

DXCM : 208.37 (+2.74%)
DexCom (DXCM) Soars to 52-Week High, Time to Cash Out?

DexCom (DXCM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

DXCM : 208.37 (+2.74%)
TMO : 306.57 (+1.90%)
EW : 245.68 (+2.13%)
STE : 148.83 (+1.42%)
Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference:

DXCM : 208.37 (+2.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade DXCM with:

Business Summary

Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.

See More

Key Turning Points

2nd Resistance Point 210.50
1st Resistance Point 206.65
Last Price 208.37
1st Support Level 198.84
2nd Support Level 194.86

See More

Last Price 208.37
52-Week High 208.20
Fibonacci 61.8% 168.80
Fibonacci 50% 156.63
Fibonacci 38.2% 144.45
52-Week Low 105.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar